| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.827 | 0.002 | 0.827 | NMDA 2 receptor antagonist | 0.706 0.003 CID_69503224 | ||
| 0.797 | 0.003 | 0.797 | NMDA receptor antagonist | 0.688 0.003 CID_69503224 | ||
| 0.762 | 0.005 | 0.792 | Spasmolytic | 0.792 0.004 CID_69503224 | CID_69503224 | |
| 0.744 | 0.005 | 0.749 | Cholesterol antagonist | 0.749 0.005 CID_69503224 | CID_69503224 | |
| 0.734 | 0.005 | 0.734 | HERG channel blocker | 0.709 0.005 CID_69503224 | ||
| 0.723 | 0.005 | 0.723 | Potassium channel (Voltage-sensitive) blocker | 0.701 0.005 CID_69503224 | ||
| 0.723 | 0.011 | 0.723 | Analgesic | 0.687 0.015 CID_69503224 | ||
| 0.675 | 0.004 | 0.675 | Antiadrenergic | 0.672 0.004 CID_69503224 | ||
| 0.67 | 0.004 | 0.67 | Adrenaline antagonist | 0.667 0.004 CID_69503224 | ||
| 0.647 | 0.011 | 0.673 | Vasodilator, peripheral | 0.673 0.008 CID_69503224 | CID_69503224 | |
| 0.608 | 0.003 | 0.608 | NMDA 2B receptor antagonist | 0.56 0.003 CID_69503224 | ||
| 0.598 | 0.005 | 0.598 | Potassium channel blocker | 0.577 0.006 CID_69503224 | ||
| 0.596 | 0.004 | 0.596 | Glutamate receptor antagonist | 0.559 0.004 CID_69503224 | ||
| 0.577 | 0.007 | 0.587 | Vasodilator | 0.587 0.006 CID_69503224 | CID_69503224 | |
| 0.565 | 0.005 | 0.591 | Cyclic AMP phosphodiesterase inhibitor | 0.591 0.004 CID_69503224 | CID_69503224 | |
| 0.56 | 0.002 | 0.56 | NMDA receptor subunit 3A antagonist | 0.403 0.003 CID_69503224 | ||
| 0.543 | 0.003 | 0.543 | NMDA 2C receptor antagonist | 0.356 0.004 CID_69503224 | ||
| 0.532 | 0.003 | 0.532 | NMDA 2A receptor antagonist | 0.363 0.003 CID_69503224 | ||
| 0.515 | 0.004 | 0.546 | Anesthetic local | 0.546 0.004 CID_69503224 | CID_69503224 | |
| 0.527 | 0.019 | 0.527 | Calcium channel L-type activator | 0.492 0.031 CID_69503224 | ||
| 0.503 | 0.029 | 0.523 | Antithrombotic | 0.523 0.026 CID_69503224 | CID_69503224 | |
| 0.436 | 0.004 | 0.436 | Nav1.1 sodium channel blocker | 0.412 0.004 CID_69503224 | ||
| 0.471 | 0.044 | 0.471 | Antiobesity | 0.456 0.048 CID_69503224 | ||
| 0.399 | 0.005 | 0.411 | Neurotrophic factor | 0.411 0.005 CID_69503224 | CID_69503224 | |
| 0.389 | 0.005 | 0.389 | CC chemokine receptor antagonist | 0.354 0.005 CID_69503224 | ||
| 0.385 | 0.031 | 0.385 | Calcium channel activator | 0.369 0.038 CID_69503224 | ||
| 0.358 | 0.005 | 0.358 | Chemokine receptor antagonist | 0.32 0.006 CID_69503224 | ||
| 0.357 | 0.006 | 0.357 | Alpha 1b adrenoreceptor antagonist | 0.326 0.007 CID_69503224 | ||
| 0.38 | 0.05 | 0.38 | 5 Hydroxytryptamine release stimulant | 0.241 0.094 CID_69503224 | ||
| 0.353 | 0.029 | 0.353 | Anticonvulsant | 0.299 0.041 CID_69503224 | ||
| 0.352 | 0.031 | 0.354 | Psychostimulant | 0.354 0.031 CID_69503224 | CID_69503224 | |
| 0.315 | 0.014 | 0.33 | Alpha adrenoreceptor antagonist | 0.33 0.013 CID_69503224 | CID_69503224 | |
| 0.337 | 0.043 | 0.353 | Cardiotonic | 0.353 0.038 CID_69503224 | CID_69503224 | |
| 0.295 | 0.004 | 0.295 | Dopamine uptake inhibitor | 0.254 0.005 CID_69503224 | ||
| 0.34 | 0.061 | 0.361 | Apoptosis antagonist | 0.361 0.051 CID_69503224 | CID_69503224 | |
| 0.303 | 0.032 | 0.31 | Tyrosine 3 hydroxylase inhibitor | 0.31 0.029 CID_69503224 | CID_69503224 | |
| 0.277 | 0.006 | 0.277 | Alpha 1d adrenoreceptor antagonist | 0.225 0.008 CID_69503224 | ||
| 0.29 | 0.028 | 0.294 | Peptidyltransferase inhibitor | 0.294 0.027 CID_69503224 | CID_69503224 | |
| 0.264 | 0.014 | 0.264 | Alpha 1 adrenoreceptor antagonist | 0.261 0.014 CID_69503224 | ||
| 0.26 | 0.013 | 0.26 | Acetylcholine muscarinic antagonist | 0.24 0.016 CID_69503224 | ||
| 0.251 | 0.005 | 0.251 | Adrenaline uptake inhibitor | 0.235 0.005 CID_69503224 | ||
| 0.244 | 0.004 | 0.244 | NMDA receptor subunit 3B antagonist | 0.155 0.006 CID_69503224 | ||
| 0.244 | 0.009 | 0.244 | 5 Hydroxytryptamine uptake inhibitor | 0.22 0.01 CID_69503224 | ||
| 0.234 | 0.009 | 0.238 | Dopamine D1 antagonist | 0.238 0.008 CID_69503224 | CID_69503224 | |
| 0.233 | 0.009 | 0.233 | Opioid antagonist | 0.194 0.015 CID_69503224 | ||
| 0.247 | 0.025 | 0.247 | Antipruritic | 0.226 0.034 CID_69503224 | ||
| 0.261 | 0.045 | 0.261 | Anesthetic general | 0.25 0.05 CID_69503224 | ||
| 0.218 | 0.007 | 0.231 | Alpha adrenoreceptor agonist | 0.231 0.006 CID_69503224 | CID_69503224 | |
| 0.224 | 0.014 | 0.224 | Alpha 1a adrenoreceptor antagonist | 0.207 0.016 CID_69503224 | ||
| 0.215 | 0.016 | 0.222 | Bronchodilator | 0.222 0.015 CID_69503224 | CID_69503224 | |
| 0.225 | 0.026 | 0.225 | Cholinergic antagonist | 0.205 0.031 CID_69503224 | ||
| 0.205 | 0.006 | 0.206 | Adrenaline agonist | 0.206 0.006 CID_69503224 | CID_69503224 | |
| 0.214 | 0.015 | 0.214 | Nav1.6 sodium channel blocker | 0.205 0.018 CID_69503224 | ||
| 0.219 | 0.026 | 0.219 | Acetylcholine antagonist | 0.199 0.031 CID_69503224 | ||
| 0.198 | 0.009 | 0.198 | Opioid mu receptor antagonist | 0.165 0.014 CID_69503224 | ||
| 0.272 | 0.096 | 0.272 | Interleukin 2 agonist | 0.262 0.106 CID_69503224 | ||
| 0.2 | 0.024 | 0.2 | Nav1.3 sodium channel blocker | 0.18 0.032 CID_69503224 | ||
| 0.187 | 0.011 | 0.187 | Opioid kappa receptor antagonist | 0.142 0.018 CID_69503224 | ||
| 0.189 | 0.016 | 0.189 | Histamine H1 receptor antagonist | 0.186 0.016 CID_69503224 | ||
| 0.209 | 0.038 | 0.209 | Acetylcholine M1 receptor antagonist | 0.194 0.045 CID_69503224 | ||
| 0.175 | 0.009 | 0.175 | Acetylcholine M3 receptor antagonist | 0.139 0.012 CID_69503224 | ||
| 0.178 | 0.011 | 0.178 | Analgesic, opioid | 0.144 0.016 CID_69503224 | ||
| 0.177 | 0.019 | 0.192 | Dopamine D2 antagonist | 0.192 0.018 CID_69503224 | CID_69503224 | |
| 0.174 | 0.023 | 0.174 | Pregnane X receptor agonist | 0.169 0.027 CID_69503224 | ||
| 0.268 | 0.117 | 0.294 | Vasodilator, coronary | 0.294 0.092 CID_69503224 | CID_69503224 | |
| 0.207 | 0.057 | 0.231 | Peroxidase inhibitor | 0.231 0.051 CID_69503224 | CID_69503224 | |
| 0.176 | 0.029 | 0.189 | Adenylate cyclase stimulant | 0.189 0.019 CID_69503224 | CID_69503224 | |
| 0.156 | 0.011 | 0.156 | Sigma receptor antagonist | 0.122 0.014 CID_69503224 | ||
| 0.147 | 0.006 | 0.147 | Dopamine transporter inhibitor | 0.141 0.007 CID_69503224 | ||
| 0.173 | 0.033 | 0.174 | Farnesoid X receptor antagonist | 0.174 0.032 CID_69503224 | CID_69503224 | |
| 0.186 | 0.047 | 0.195 | Melanin inhibitor | 0.195 0.043 CID_69503224 | CID_69503224 | |
| 0.162 | 0.024 | 0.173 | Dopamine antagonist | 0.173 0.022 CID_69503224 | CID_69503224 | |
| 0.157 | 0.021 | 0.177 | Alpha 2a adrenoreceptor antagonist | 0.177 0.017 CID_69503224 | CID_69503224 | |
| 0.151 | 0.02 | 0.151 | 5 Hydroxytryptamine 1A antagonist | 0.123 0.025 CID_69503224 | ||
| 0.175 | 0.044 | 0.175 | Cell wall synthesis inhibitor | 0.17 0.047 CID_69503224 | ||
| 0.151 | 0.024 | 0.151 | Creatine kinase inhibitor | 0.134 0.032 CID_69503224 | ||
| 0.141 | 0.015 | 0.141 | Lanosterol 14 alpha demethylase inhibitor | 0.116 0.035 CID_69503224 | ||
| 0.158 | 0.032 | 0.167 | Sphingosine 1-phosphate receptor 2 antagonist | 0.167 0.023 CID_69503224 | CID_69503224 | |
| 0.223 | 0.1 | 0.26 | Interleukin agonist | 0.26 0.071 CID_69503224 | CID_69503224 | |
| 0.182 | 0.059 | 0.182 | MAP kinase kinase 5 inhibitor | 0.181 0.062 CID_69503224 | ||
| 0.155 | 0.033 | 0.155 | Ca2+-transporting ATPase inhibitor | 0.15 0.042 CID_69503224 | ||
| 0.191 | 0.07 | 0.209 | P-glycoprotein inhibitor | 0.209 0.058 CID_69503224 | CID_69503224 | |
| 0.125 | 0.005 | 0.125 | Nociceptin (N/OFQ) receptor antagonist | 0.102 0.006 CID_69503224 | ||
| 0.127 | 0.009 | 0.134 | Beta adrenoreceptor antagonist | 0.134 0.008 CID_69503224 | CID_69503224 | |
| 0.165 | 0.049 | 0.165 | Nav1.2 sodium channel blocker | 0.132 0.071 CID_69503224 | ||
| 0.213 | 0.098 | 0.213 | Neuropeptide Y2 antagonist | 0.178 0.163 CID_69503224 | ||
| 0.155 | 0.042 | 0.172 | Adenylate cyclase inhibitor | 0.172 0.033 CID_69503224 | CID_69503224 | |
| 0.128 | 0.016 | 0.16 | Phenylalanine 4-hydroxylase inhibitor | 0.16 0.01 CID_69503224 | CID_69503224 | |
| 0.139 | 0.031 | 0.156 | Alpha 2 adrenoreceptor antagonist | 0.156 0.026 CID_69503224 | CID_69503224 | |
| 0.158 | 0.05 | 0.166 | Sphingosine 1-phosphate receptor 5 antagonist | 0.166 0.039 CID_69503224 | CID_69503224 | |
| 0.243 | 0.136 | 0.243 | Sodium/bile acid cotransporter inhibitor | 0.227 0.154 CID_69503224 | ||
| 0.221 | 0.115 | 0.258 | 5 Hydroxytryptamine uptake stimulant | 0.258 0.073 CID_69503224 | CID_69503224 | |
| 0.19 | 0.084 | 0.204 | Insulin sensitizer | 0.204 0.069 CID_69503224 | CID_69503224 | |
| 0.135 | 0.032 | 0.135 | Estrogen antagonist | 0.118 0.059 CID_69503224 | ||
| 0.109 | 0.007 | 0.109 | CC chemokine 5 receptor antagonist | 0.1 0.008 CID_69503224 | ||
| 0.121 | 0.026 | 0.121 | Opioid delta receptor antagonist | 0.086 0.034 CID_69503224 | ||
| 0.113 | 0.021 | 0.113 | Estrogen receptor alpha antagonist | 0.106 0.024 CID_69503224 | ||
| 0.197 | 0.106 | 0.206 | Aldehyde oxidase inhibitor | 0.206 0.101 CID_69503224 | CID_69503224 | |
| 0.093 | 0.004 | 0.093 | GABA uptake inhibitor | 0.084 0.005 CID_69503224 | ||
| 0.183 | 0.095 | 0.202 | Neurotrophic factor enhancer | 0.202 0.075 CID_69503224 | CID_69503224 | |
| 0.118 | 0.031 | 0.118 | 5 Hydroxytryptamine 1 antagonist | 0.095 0.039 CID_69503224 | ||
| 0.118 | 0.034 | 0.118 | Estrogen receptor beta antagonist | 0.101 0.063 CID_69503224 | ||
| 0.1 | 0.021 | 0.1 | CC chemokine 5 receptor agonist | 0.083 0.054 CID_69503224 | ||
| 0.095 | 0.016 | 0.099 | Beta 3 adrenoreceptor antagonist | 0.099 0.015 CID_69503224 | CID_69503224 | |
| 0.121 | 0.042 | 0.124 | Antihistaminic | 0.124 0.041 CID_69503224 | CID_69503224 | |
| 0.119 | 0.045 | 0.119 | Toll-Like receptor 4 antagonist | 0.114 0.05 CID_69503224 | ||
| 0.085 | 0.013 | 0.085 | Neurokinin 2 antagonist | 0.073 0.015 CID_69503224 | ||
| 0.079 | 0.008 | 0.079 | Substance P antagonist | 0.072 0.009 CID_69503224 | ||
| 0.095 | 0.029 | 0.099 | Leukotriene synthesis inhibitor | 0.099 0.027 CID_69503224 | CID_69503224 | |
| 0.111 | 0.049 | 0.111 | Anabolic | 0.1 0.062 CID_69503224 | ||
| 0.08 | 0.019 | 0.08 | Opioid agonist | 0.063 0.028 CID_69503224 | ||
| 0.104 | 0.045 | 0.104 | Histamine antagonist | 0.104 0.045 CID_69503224 | ||
| 0.077 | 0.018 | 0.077 | Opioid mu receptor agonist | 0.055 0.026 CID_69503224 | ||
| 0.118 | 0.06 | 0.122 | Alpha 2b adrenoreceptor antagonist | 0.122 0.057 CID_69503224 | CID_69503224 | |
| 0.277 | 0.22 | 0.297 | Caspase 9 stimulant | 0.297 0.197 CID_69503224 | CID_69503224 | |
| 0.121 | 0.064 | 0.127 | Cholesterol synthesis inhibitor | 0.127 0.059 CID_69503224 | CID_69503224 | |
| 0.112 | 0.056 | 0.113 | Alpha 2c adrenoreceptor antagonist | 0.113 0.055 CID_69503224 | CID_69503224 | |
| 0.211 | 0.159 | 0.24 | Transcription factor NF kappa B inhibitor | 0.24 0.134 CID_69503224 | CID_69503224 | |
| 0.059 | 0.008 | 0.059 | Sigma 2 receptor antagonist | 0.044 0.011 CID_69503224 | ||
| 0.088 | 0.04 | 0.088 | Interferon agonist | 0.079 0.053 CID_69503224 | ||
| 0.142 | 0.094 | 0.142 | Growth hormone agonist | |||
| 0.111 | 0.065 | 0.111 | 5 Hydroxytryptamine 2 antagonist | 0.101 0.071 CID_69503224 | ||
| 0.122 | 0.076 | 0.122 | Papain-like protease (SARS coronavirus) inhibitor | 0.115 0.097 CID_69503224 | ||
| 0.151 | 0.105 | 0.173 | Platelet adhesion inhibitor | 0.173 0.086 CID_69503224 | CID_69503224 | |
| 0.193 | 0.148 | 0.234 | Lipoxygenase inhibitor | 0.234 0.111 CID_69503224 | CID_69503224 | |
| 0.065 | 0.022 | 0.065 | Neurokinin antagonist | 0.057 0.027 CID_69503224 | ||
| 0.073 | 0.031 | 0.073 | Interferon inducer | 0.066 0.041 CID_69503224 | ||
| 0.12 | 0.078 | 0.12 | Alpha-N-acetylglucosaminidase inhibitor | 0.105 0.094 CID_69503224 | ||
| 0.054 | 0.012 | 0.054 | Beta adrenoreceptor agonist | 0.054 0.012 CID_69503224 | ||
| 0.047 | 0.006 | 0.047 | Estrogen-related receptor beta antagonist | 0.036 0.015 CID_69503224 | ||
| 0.082 | 0.042 | 0.092 | Glutamate decarboxylase inhibitor | 0.092 0.034 CID_69503224 | CID_69503224 | |
| 0.06 | 0.024 | 0.063 | Beta 2 adrenoreceptor antagonist | 0.063 0.021 CID_69503224 | CID_69503224 | |
| 0.105 | 0.072 | 0.12 | Electron transport complex I inhibitor | 0.12 0.047 CID_69503224 | CID_69503224 | |
| 0.065 | 0.032 | 0.066 | Beta 2 adrenoreceptor agonist | 0.066 0.029 CID_69503224 | CID_69503224 | |
| 0.087 | 0.054 | 0.087 | 5 Hydroxytryptamine 2A antagonist | 0.078 0.06 CID_69503224 | ||
| 0.081 | 0.048 | 0.081 | Viral attachment inhibitor | 0.079 0.051 CID_69503224 | ||
| 0.057 | 0.026 | 0.057 | Potassium channel (Inward rectifier) blocker | 0.05 0.034 CID_69503224 | ||
| 0.063 | 0.033 | 0.063 | Alpha 1 adrenoreceptor agonist | 0.063 0.033 CID_69503224 | ||
| 0.05 | 0.019 | 0.05 | Neurokinin 1 antagonist | 0.045 0.023 CID_69503224 | ||
| 0.107 | 0.079 | 0.115 | Microtubule formation inhibitor | 0.115 0.066 CID_69503224 | CID_69503224 | |
| 0.094 | 0.067 | 0.102 | Sphingomyelinase inhibitor | 0.102 0.057 CID_69503224 | CID_69503224 | |
| 0.079 | 0.052 | 0.079 | Somatostatin 1 agonist | |||
| 0.112 | 0.086 | 0.129 | Amylase inhibitor | 0.129 0.075 CID_69503224 | CID_69503224 | |
| 0.119 | 0.093 | 0.128 | Protein kinase stimulant | 0.128 0.085 CID_69503224 | CID_69503224 | |
| 0.035 | 0.009 | 0.035 | Estrogen-related receptor gamma antagonist | 0.03 0.016 CID_69503224 | ||
| 0.062 | 0.039 | 0.062 | Acetylcholine M5 receptor antagonist | 0.056 0.048 CID_69503224 | ||
| 0.064 | 0.041 | 0.064 | Acetylcholine M2 receptor antagonist | |||
| 0.041 | 0.02 | 0.041 | Estrogen receptor alpha agonist | |||
| 0.071 | 0.051 | 0.071 | Phospholipase D inhibitor | |||
| 0.134 | 0.114 | 0.152 | Nitric oxide antagonist | 0.152 0.093 CID_69503224 | CID_69503224 | |
| 0.11 | 0.09 | 0.111 | Cyclooxygenase 3 inhibitor | 0.111 0.088 CID_69503224 | CID_69503224 | |
| 0.029 | 0.01 | 0.029 | Nociceptin (N/OFQ) receptor agonist | 0.023 0.013 CID_69503224 | ||
| 0.152 | 0.134 | 0.152 | Hypolipemic | 0.149 0.138 CID_69503224 | ||
| 0.055 | 0.038 | 0.055 | CC chemokine 2 receptor antagonist | |||
| 0.031 | 0.014 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.016 CID_69503224 | ||
| 0.097 | 0.08 | 0.097 | Nav1.4 sodium channel blocker | |||
| 0.044 | 0.028 | 0.046 | Nerve growth factor antagonist | 0.046 0.024 CID_69503224 | CID_69503224 | |
| 0.045 | 0.029 | 0.049 | Dopamine D5 antagonist | 0.049 0.026 CID_69503224 | CID_69503224 | |
| 0.059 | 0.044 | 0.062 | Alpha 2 adrenoreceptor agonist | 0.062 0.04 CID_69503224 | CID_69503224 | |
| 0.074 | 0.059 | 0.074 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.031 | 0.017 | 0.031 | Potassium channel (Inward rectifier) 1 blocker | 0.031 0.019 CID_69503224 | ||
| 0.086 | 0.072 | 0.086 | Prolactin inhibitor | 0.084 0.074 CID_69503224 | ||
| 0.092 | 0.081 | 0.092 | mTOR complex 1 inhibitor | |||
| 0.08 | 0.069 | 0.08 | mTOR complex 2 inhibitor | |||
| 0.042 | 0.032 | 0.042 | Opioid kappa receptor agonist | |||
| 0.038 | 0.028 | 0.044 | Alpha 1d adrenoreceptor agonist | 0.044 0.021 CID_69503224 | CID_69503224 | |
| 0.025 | 0.015 | 0.025 | CC chemokine 1 receptor antagonist | |||
| 0.085 | 0.076 | 0.114 | 5-Lipoxygenase inhibitor | 0.114 0.053 CID_69503224 | CID_69503224 | |
| 0.244 | 0.236 | 0.244 | 5 Hydroxytryptamine release inhibitor | |||
| 0.031 | 0.023 | 0.031 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.023 | 0.015 | 0.024 | Beta 1 adrenoreceptor agonist | 0.024 0.014 CID_69503224 | CID_69503224 | |
| 0.038 | 0.031 | 0.042 | Dopamine D5 agonist | 0.042 0.025 CID_69503224 | CID_69503224 | |
| 0.045 | 0.039 | 0.046 | Cholesterol esterase inhibitor | 0.046 0.036 CID_69503224 | CID_69503224 | |
| 0.044 | 0.039 | 0.044 | Estrogen agonist | |||
| 0.043 | 0.038 | 0.043 | Potassium channel Kv1.3 blocker | |||
| 0.087 | 0.086 | 0.097 | Expectorant | 0.097 0.072 CID_69503224 | CID_69503224 | |
| 0.089 | 0.096 | 0.096 | Mucolytic | 0.096 0.084 CID_69503224 | CID_69503224 | |
| 0.017 | 0.03 | 0.026 | Dopamine D1 agonist | 0.026 0.012 CID_69503224 | CID_69503224 | |
| 0.042 | 0.056 | 0.049 | Squalene epoxidase inhibitor | 0.049 0.036 CID_69503224 | CID_69503224 | |
| 0.161 | 0.178 | 0.169 | Nitric-oxide synthase stimulant | 0.169 0.156 CID_69503224 | CID_69503224 | |
| 0.069 | 0.098 | 0.099 | HIV-1 integrase (Overall Integration) inhibitor | 0.099 0.055 CID_69503224 | CID_69503224 | |
| 0.042 | 0.075 | 0.067 | Dopamine agonist | 0.067 0.047 CID_69503224 | CID_69503224 | |
| 0.164 | 0.198 | 0.182 | Hypoxia-inducible factor 1 alpha inhibitor | 0.182 0.175 CID_69503224 | CID_69503224 | |
| 0.064 | 0.149 | 0.081 | Vanilloid agonist | 0.081 0.067 CID_69503224 | CID_69503224 | |
| 0.116 | 0.218 | 0.177 | Antioxidant | 0.177 0.135 CID_69503224 | CID_69503224 | |
| 0.056 | 0.159 | 0.128 | M18 aspartyl aminopeptidase inhibitor | 0.128 0.065 CID_69503224 | CID_69503224 | |
| 0.083 | 0.267 | 0.152 | Free radical scavenger | 0.152 0.143 CID_69503224 | CID_69503224 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |